Plasma in the PICU: why and when should we transfuse?

Area of Science:

• Transfusion Medicine
• Critical Care Medicine
• Hematology

Background:

• Plasma transfusions have evolved from volume replacement to treating coagulation deficiencies.
• Plasma is a common treatment in intensive care units for both adult and pediatric patients.
• Historical use of plasma transfusions dates back to World War II.

Purpose of the Study:

• To review current evidence on plasma transfusions.
• To discuss the appropriate indications for plasma use in clinical practice.
• To evaluate the risks versus benefits of plasma transfusions.

Main Methods:

• Review of observational studies on plasma transfusion efficacy.
• Analysis of epidemiological data regarding plasma transfusion outcomes.
• Synthesis of expert recommendations on plasma transfusion guidelines.

Main Results:

• Observational studies indicate plasma transfusions may not effectively correct mild coagulation abnormalities.
• Epidemiological data suggest an association between plasma transfusions and increased morbidity and mortality in critically ill patients.
• Current evidence challenges the routine use of plasma in non-bleeding patients.

Conclusions:

• Plasma transfusions should be reserved for patients with massive bleeding or documented coagulation defects.
• The use of plasma should be carefully considered, weighing potential benefits against risks.
• Limiting plasma transfusions to specific indications may improve patient outcomes in critical care settings.